7 unknown. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Unknown 7 |
Follow Urticaria: new trials by email Literature Review of Urticaria trials Research Report on Urticaria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Histamine Human Immunoglobulin in the Treatment of Chronic Spontaneous Urticaria (CSU) human histaglobulin, placebo, Loratadine 10 Mg - Chronic Spontaneous Urticaria | Phase 4 | Unknown | Hangzhou Grand Biologic Pharmaceutical, Inc. | 252 | 2024-03-31 | 2024-02-09 |
| Molecular Endotypes of Chronic Idiopathic Urticaria Omalizumab - Chronic Urticaria, Idiopathic | Phase 4 | Unknown | University of Colorado, Denver | 15 | 2022-01-01 | 2024-08-15 |
| Study on the Correlation Between Intestinal Microecology and Allergic Diseases in Children probiotics, conventional medical treatment - Rhinitis, Allergic, Asthma | Phase 4 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 200 | 2020-03-01 | 2021-06-24 |
| Tranexamic Acid and Spontaneous Chronic Urticaria association of levocetirizine and tranexamic acid, Levocetirizine only - Chronic Spontaneous Urticaria | Phase 4 | Unknown | University Hospital, Grenoble | 80 | 2019-12-10 | 2021-04-28 |
| A Trial to Evaluate the Effect of Vitamin D Supplementation in Patients With Chronic Urticaria Vit D - Urticaria, Vitamin D Deficiency | Phase 4 | Unknown | Post Graduate Institute of Medical Education and Research, Chandigarh | 262 | 2019-06-21 | 2019-06-24 |
| Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome Dapsone, HLA-B*1301 - Allergic Cutaneous Vasculitis, Urticaria | Phase 4 | Unknown | Shandong Provincial Institute of Dermatology and Venereology | 3130 | 2015-07-01 | 2017-03-03 |
| The Efficacy and Safety of Desloratadine With Levocetirizine in Treatment of Chronic Idiopathic Urticaria Denosin® and Xyzal® - Chronic Idiopathic Urticaria, Urticaria | Phase 4 | Unknown | Lotus Pharmaceutical | 60 | 2006-01-01 | 2006-06-30 |
Chronic Urticaria (4) · Acne Vulgaris (1) · Asthma (1) · Dermatitis, Atopic (1) · Hypersensitivity (1) · Leprosy (1) · Pneumonia, Pneumocystis (1) · Psoriasis (1) · Rhinitis, Allergic (1) · Skin Diseases, Vesiculobullous (1) · Vasculitis, Leukocytoclastic, Cutaneous (1) · Vitamin D Deficiency (1)
Hypersensitivity, Immediate (7) · Immune System Diseases (7) · Skin Diseases (7) · Skin Diseases, Vascular (7) · Skin and Connective Tissue Diseases (7) · Hypersensitivity (6) · Chronic Disease (4) · Disease Attributes (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Lung Diseases (2) · Respiratory Tract Diseases (2) · Acneiform Eruptions (1) · Actinomycetales Infections (1)
levocetirizine (2) · Dapsone (1) · Loratadine (1) · Omalizumab (1) · Probiotics (1) · Tranexamic Acid (1)
Hangzhou Grand Biologic Pharmaceutical, Inc. (1) · Lotus Pharmaceutical (1) · Post Graduate Institute of Medical Education and Research, Chandigarh (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · Shandong Provincial Institute of Dermatology and Venereology (1) · University Hospital, Grenoble (1) · University of Colorado, Denver (1)
China (2) · France (1) · India (1) · Taiwan (1) · United States (1)
Davinder Parsad, MD (1) · Furen Zhang (1) · Jenny Stitt, M.D. (1) · Jia-Yu Chu (1)